Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 240,863 m |
| EPS, EUR | 2.75 |
| P/B ratio | 6.3 |
| P/E ratio | 30.5 |
| Dividend yield | 1.66% |
| Revenue, EUR | 50,010 m |
| Net income, EUR | 6,506 m |
| Profit margin | 13.01% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 3.77% | Equity United States Health Care Biotech | 49 |
| Leverage Shares 5x Long Nasdaq 100 ETP | 0.38% | Equity United States Technology | 21 |
| Leverage Shares -5x Short Nasdaq 100 ETP | 0.38% | Equity United States Technology | 8 |
| YTD | - |
| 1 month | - |
| 3 months | - |
| 6 months | - |
| 1 year | - |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | - |
| 2025 | +24.41% |
| 2024 | +3.67% |
| 2023 | -3.39% |
| 2022 | +23.35% |
| Volatility 1 year | 26.07% |
| Volatility 3 years | 22.76% |
| Volatility 5 years | 23.31% |
| Return per risk 1 year | 0.56 |
| Return per risk 3 years | 0.39 |
| Return per risk 5 years | 0.57 |
| Maximum drawdown 1 year | -20.82% |
| Maximum drawdown 3 years | -26.81% |
| Maximum drawdown 5 years | -26.81% |
| Maximum drawdown since inception | -26.81% |